key: cord-0944966-mxqwgpds authors: Odriozola, Ariel; Ortega, Lucía; Martinez, Lidia; Odriozola, Samantha; Torrens, Ainhoa; Corroleu, David; Martínez, Silvia; Ponce, Meritxell; Meije, Yolanda; Presas, Mercedes; Duarte, Alejandra; Belén Odriozola, M.; Malik, Rayaz A. title: Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection date: 2020-12-17 journal: Diabetes Res Clin Pract DOI: 10.1016/j.diabres.2020.108631 sha: 9247173015fd01f8f6967c70f553f1553a2f2228 doc_id: 944966 cord_uid: mxqwgpds Aims To characterize the distribution and severity of sensory neuropathy using a portable quantitative sensory testing (QST) device in diabetic patients (DM) hospitalized with severe COVID-19 infection. Methods Four patients with diabetes and severe SARS-CoV-2 requiring non-invasive ventilation for a protracted duration underwent clinical, laboratory and radiologic assessment and detailed evaluation of neuropathic symptoms, neurological assessment, QST on the dorsum of the foot and face using NerveCheck Master with assessment of taste and smell. Results All four subjects developed neuropathic symptoms characterized by numbness in the feet with preserved reflexes. QST confirmed symmetrical abnormality of vibration and thermal thresholds in both lower limbs in all patients and an abnormal heat pain threshold on the face of two patients and altered taste and smell. Conclusions Severe COVID-19 infection with hypoxemia is associated with neuropathic symptoms and widespread sensory dysfunction in patients with DM. warm and heat pain perception thresholds. We have previously used a simple quantitative sensory testing device called NerveCheck Master to quantify small and large nerve fibre dysfunction in patients with diabetic neuropathy . In this preliminary report we describe the detailed neurological presentation and undertake quantitative sensory testing in the feet and face and evaluate taste and smell in 4 patients with diabetes who developed severe COVID-19 disease. The study was performed in accordance with the principles of the Declaration of The room temperature ranged between 18-28°C and the temperature of the skin was between 34-36 °C. The starting (adaptation) temperature was 32°C and to prevent thermal injury, the highest temperature limit was set at 49°C and lowest temperature limit was set at 15°C. VPT was assessed at the 1st metatarsal and thermal thresholds were assessed on the dorsal area of the feet and lateral aspect of the face . Three patients with type 2 diabetes and 1 patient with type 1 diabetes developed neuropathic symptoms and were referred to neurology for further evaluation. The clinical, laboratory, COVID-19 related therapy and detailed neurological examination and QST findings in these 4 patients are presented in Tables 1 and 2 With further deterioration he was transferred to the ICU on 19 th April for non-invasive mechanical ventilation and PEEP. On 26 th April he recovered to return to the medical ward and 45 days after admission he was discharged from hospital to home ( Table 1 ). The patient reported numbness but no pain in the feet. The patellar and Achilles deep tendon reflexes were normal with a bilateral flexor plantar response. On the feet, VPT and HPT were abnormal and CPT was normal. On the face HPT was normal. Taste was absent for sweet and salt, smell was present for acetone, perfume and coffee. There was no evidence of the Vernet phenomenon and the oropharyngeal reflex was absent ( Table 2 ). A 68-year-old male with T1DM developed fever, nausea and a cough with dyspnoea and weakness on March 26th, 2020. On April 9 th (day 14) he was admitted to hospital with hypoxemia, diagnosed with COVID-19 pneumonia and treated with Lopinavir-Ritonavir, hydroxychloroquine, ceftriaxone, azithromycin and on day 3 of admission, tocilizumab. On April 13 th (day 18) he was admitted to the ICU to receive NIMV (CPAP) and steroids. After 6 days in ICU, he returned to the ward and was discharged from hospital to home on May 8 th (day 43). Serial blood tests showed an IL-6 increased from 111.20 pg/mL to 424 pg/ml on day 16 with an increase in the D-dimer from 535 ng/mL on admission to 6739 ng/mL on day 19 ( Table 1) . The patient reported numbness and pain in both feet. The patellar and Achilles deep tendon reflexes were normal except for an absent left Achilles reflex, with a bilateral flexor plantar response. On the feet, VPT and CPT were symmetrically abnormal, whilst WPT and HPT were abnormal on the left and normal on the right. On the face HPT was abnormal. Taste was present for sweet and salt, smell was absent for acetone, perfume and coffee. There was no evidence of the Vernet phenomenon and the oropharyngeal reflex was absent ( Table 2) . Table 1 ). The patient reported numbness but no pain in the feet. The patellar and Achilles deep tendon reflexes were normal, with a bilateral flexor plantar response. On the feet, VPT, CPT, WPT and HPT were symmetrically abnormal. On the face HPT was normal. Taste was present for sweet and salt, smell was absent for acetone, perfume and coffee. There was no evidence of the Vernet phenomenon and the oropharyngeal reflex was normal (Table 2) . Table 1 ). The patient reported numbness but no pain in the feet. The patellar deep tendon reflexes were normal but both Achilles reflexes were abnormal, with a bilateral flexor plantar response. On the feet, VPT, CPT, WPT and HPT were abnormal, except for a normal CPT on the right foot. On the face HPT was abnormal. Taste was absent for sweet and present for salt, whilst smell was present for acetone, perfume and absent for coffee. There was no evidence of the Vernet phenomenon and the oropharyngeal reflex was normal ( Table 2) . We report neuropathic symptoms and abnormal quantitative sensory testing in patients with T1DM and T2DM after prolonged admission for COVID-19 pneumonia. All four patients had distal numbness in the lower extremities with preserved deep tendon reflexes in three. In the case series from Wuhan, only 2.3% reported neuropathic pain, but this was 4-fold greater in those with more severe illness ( We also show elevated heat pain thresholds in the trigeminal sensory distribution on the face in two out of four patients. Indeed, a case of bifacial weakness with paresthesia, without ataxia or other cranial neuropathies has been temporally associated with antecedent COVID-19 (Hutchins et al 2020) . Furthermore, whilst taste was relatively preserved, the sense of smell to irritant and non-irritant stimuli was reduced from presentation until hospital discharge in three out of four patients. We also report an abnormal oropharyngeal gag reflex in two patients, although the Vernet phenomenon was normal in all patients. A recent case report has described a 70-year-old male who developed dysphagia and aspiration pneumonia during recovery from severe COVID-19. Barcelona, Spain. We thank the laboratory staff at Hospital de Barcelona SCIAS and the Hospital Director Dr Miquel Gómez whose offered a very professional service to our study subjects and for always being extra helpful. We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to financial contributions to this work. Phi Med Europe S.L. provided the NerveCheck device. S. Odriozola, M.B. Odriozola and A. Odriozola are the owners and inventors of the NerveCheck. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. The Barcelona Hospital contributed to the study, providing the individual protection equipment for COVID-19 and the hospital facilities. Phi Med Europe loaned the NerveCheck equipment free of charge. The study participants did not receive grants or economic rewards of any kind. Table1. Clinical and laboratory data, therapy and neurologic manifestations. ND: Not done, Present: +, CRP: C-reactive protein, ALT: Alanine Transaminase, AST: Aspartate Aminotransferase. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus A first case of meningitis/encephalitis associated with SARScoronavirus-2 Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4 Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice Brain stem projections of sensory and motor components of the vagus complex in the cat: II. Laryngeal, tracheobronchial, pulmonary, cardiac, and gastrointestinal branches CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study Diabetic Neuropathy: A Position Statement by the American Diabetes Association Diagnosing Diabetic Neuropathy: Something Old, Something New Diabetic neuropathy: A focus on small fibres NerveCheck: An inexpensive quantitative sensory testing device for patients with diabetic neuropathy NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes Neurological associations of COVID-19 A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys Diagnosing peripheral neuropathy in South-East Asia: A focus on diabetic neuropathy Diabetic neuropathy and painful diabetic neuropathy: Cinderella complications in South East Asia Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar Prevalence and management of diabetic neuropathy in secondary care in Qatar Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models Challenges of neuropathic pain: focus on diabetic neuropathy COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome Neural Regen Res Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report Corneal confocal microscopy: ready for prime time Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients Nerve Loss Detected With Corneal Confocal Microscopy Is Symmetrical and Related to the Severity of Diabetic Polyneuropathy Corneal Confocal Microscopy Detects Small-Fiber Neuropathy in Burning Mouth Syndrome: A Cross-Sectional Study Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study Evidence for small fiber neuropathy in early Parkinson's disease Corneal Confocal Microscopy: An Imaging Endpoint for Axonal Degeneration in Multiple Sclerosis Use of Corneal Confocal Microscopy to Detect Corneal Nerve Loss and Increased Dendritic Cells in Patients With Multiple Sclerosis Association of corneal nerve fiber measures with cognitive function in dementia